The clinical analysis laboratory sector registered revenues of 1.73 billion euros in 2025, representing a 3% increase compared to the previous year, according to data released this Thursday by DBK Informa in a note.
According to the consultancy, in 2025 the sector's turnover maintained a path of "sustained growth," supported by the increase in demand for diagnostic services, linked to greater public awareness of health and prevention.
If the total market value is analyzed, including both private laboratories and those integrated into healthcare centers with internal management, the volume reached 3.83 billion euros, with private laboratories accounting for around 45% of that amount.
In parallel, the number of healthcare centers authorized to perform clinical analysis and registered in the General Registry of the Ministry of Health stood at nearly 1,800 in June 2026, including both public and private facilities.
Within this group, 829 are diagnostic centers specializing in clinical analysis. Of these, around twenty are publicly owned, while more than 800 belong to private companies.
Regarding the sector's configuration, the landscape is dominated by small companies operating a single laboratory, coexisting with a small group of large business operators, some of them subsidiaries of foreign multinational groups.
The study reflects, in summary, that the five largest competitors by revenue volume concentrate more than 35% of the total turnover of private laboratories, a percentage that approaches 50% when the analysis is extended to the ten main operators.